THIRUVANANTHAPURAM: The National Centre for Disease Informatics and Research (NCDIR) projects that by 2030, every year cancer ...

Queen’s University Belfast’s Northern Ireland Cancer Registry (NICR) has published comprehensive data on cancer in Northern ...

They call for targetted interventions to improve the awareness of risk factors for cancer and to encourage early diagnosis ...

For decades, oral healthcare has mainly focused on preventing cavities and gum disease. However, scientific research has ...

5 Early recurrence is associated with poorer prognosis and shorter survival.5,6 Tumor size ... et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and ...

Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest ...

Updated threshold values of preoperative serum calcitonin predict different extents of lymph node metastasis (LNM) in ...

Pembrolizumab demonstrated promising efficacy and safety in anaplastic thyroid cancer based on pooled survival and tumor ...

Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the ...

Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have ...

Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years.

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.